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Abstract
The fundamental importance of the proteoglycan versican to early heart formation was clearly demonstrated by the Vcan
null mouse called heart defect (hdf). Total absence of the Vcan gene halts heart development at a stage prior to the heart’s
pulmonary/aortic outlet segment growth. This creates a problem for determining the significance of versican’s expression in
the forming valve precursors and vascular wall of the pulmonary and aortic roots. This study presents data from a mouse
model, Vcan(tm1Zim), of heart defects that results from deletion of exon 7 in the Vcan gene. Loss of exon 7 prevents
expression of two of the four alternative splice forms of the Vcan gene. Mice homozygous for the exon 7 deletion survive
into adulthood, however, the inability to express the V2 or V0 forms of versican results in ventricular septal defects, smaller
cushions/valve leaflets with diminished myocardialization and altered pulmonary and aortic outflow tracts. We correlate
these phenotypic findings with a large-scale differential protein expression profiling to identify compensatory alterations in
cardiac protein expression at E13.5 post coitus that result from the absence of Vcan exon 7. The Vcan(tm1Zim) hearts show
significant changes in the relative abundance of several cytoskeletal and muscle contraction proteins including some
previously associated with heart disease. These alterations define a protein fingerprint that provides insight to the observed
deficiencies in pre-valvular/septal cushion mesenchyme and the stability of the myocardial phenotype required for
alignment of the outflow tract with the heart ventricles.
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Introduction
During embryonic development, the extracellular matrix plays a
central role in restructuring the single heart tube into a mature
multi-chambered organ. To date, only two structural components
of the extracellular matrix, versican and its binding partner
hyaluronan, have been shown to be indispensably required for
successful completion of this morphogenetic transition. Complete
loss of either of these matrix molecules results in early embryonic
lethality with a failure of endocardial cushion formation and a
highly dilated myocardium of the primitive heart tube [1,2].
Versican is a chondroitin sulfate proteoglycan that was first
identified in fibroblastic extracts [3]. Versican is abundantly
expressed within the extracellular matrix compartment of the
developing and mature cardiovascular system. Alterations in its
expression have been associated with vascular disease [4] and its
expression is required early for normal early heart development
[5]. The versican gene (Vcan; formerly Cspg2) consists of 15 exons
and spans a region of approximately 100 kb [6,7]. The exons
encode modular protein domains whose presence in the protein
core is regulated by alternative splicing of the mRNA [8,9]. At
least 4 different mRNA splice forms (V0, V1, V2 and V3) have
been identified in adult tissue and are produced by the alternative
splicing of exons 7 and 8 (Fig. 1). Several studies of expression have
shown that these alternatively spliced mRNA forms are differen-
tially expressed in specific tissues types, e.g. brain, smooth muscle,
tumors, suggesting that the regulation of functional domains
within versican are required for differentiation and persistence of a
tissue’s phenotype [9–15]. Additionally, the activity of versican’s
protein domains may be altered by selective proteolysis. Two of
the splice forms V0 & V1 have specific cleavage sites (DPEAAE)
found within target substrates of metalloproteinase ADAMTS-1
[16]. Proteolytic processing of versican occurs during changes in
the vascular system [16–18] and during critical stages of heart
development [19–21].
As shown by the heart defect mouse (hdf), the absence of versican
protein results in early embryonic lethality [5]. Embryonic mice
homozygous for the hdf allele display severe cardiac defects
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including absence of pre-valvular endocardial cushions, loss of
anterior (second) heart field structures and a thin, dilated
myocardium. Similarly, loss of a subdomain of the G1 domain
(found in all Vcan splice forms) results in embryonic lethality of
homozygous embryos on a congenic and mixed background.
However, on the mixed background some embryos survive longer
and have ventricular septal defects [22]. The purpose of the this
study was to determine the functional significance of an imbalance
in Vcan’s alternative splice forms at later stages of heart
development using a versican alternative splice form deficient
mouse model. The Vcan(tm1Zim) mouse, expresses only the V1 and
V3 splice forms of versican in the heart and survive embryogenesis
[23]. We demonstrate that mice homozygous for the Vcan(tm1Zim)
deletion have less severe cardiac defects than the hdf homozygous
mice. Differential protein expression profiling using isobaric tag
reagents for absolute and relative quantitation (iTRAQ) [24]
coupled with shotgun proteomics was used to identify some of the
responsive changes in cellular protein expression that result from
the loss of versican V2/V0 splice forms.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol (AR#1572) was approved by the Institutional Animal
Care & Use Committee (IACUC) at the Medical University of
South Carolina. Wild-type C57BL6/J and Vcan(tm1Zim) hearts were
collected from timed pregnant dams and staged according to
Theiler [25] before being processed for analysis as described
below.
Generation of the Vcan(tm1Zim) Mice
The Vcan(tm1Zim) mice were created and characterized as
described elsewhere [23] Briefly, by homologous recombination,
an endoplasmic reticulum retention signal, a stop codon and a
floxed neo-tk cassette were incorporated in exon 7 of the versican
gene (V0/V2 neo-tk). The selection cassette was removed by
crossing these heterozygous mice with a CRE-deleter strain
eliminating exon 7 [26,27]. Genotyping of genomic DNA from
progeny of hemizygous matings was performed by PCR using the
following exon 7 specific primers: 59-GAGAGGACAGAAACAC-
CAAG-39, 59-ACTGTGGGTCAAATGAACTC-39 designed to
yield a 454 bp product from the mutated allele and a 312 bp
product from the wild-type allele. The absence of the V0 and V2
splice forms was independently confirmed in our laboratory by
immunohistochemistry and western blot analysis.
Rapid Confocal Morphological Analysis of Intact
Embryonic Mouse Hearts
To evaluate the whole mouse embryo hearts by optical
sectioning, we adapted a confocal fluorescence imaging technique
originally used with avian hearts [28]. Embryonic day 13.5 hearts
were perfused in situ with modified saline (buffered saline solution
containing 30 mM KCl & 10 ug/ml verapamil) to remove blood
and suspend all the hearts in the same state of contraction.
Buffered saline containing FITC conjugated poly-L-lysine was
then perfused into the hearts to enhance visualization of the
endothelial lining of the hearts and vessels prior to fixation with
Figure 1. Splice forms of versican. The Vcan gene consists of 15 exons. Four mRNA and corresponding protein variants of the core protein (V0,
V1, V2, V3) are derived from alternative splicing of exons 7 (blue boxes) and/or 8 (green boxes) into mRNA of Vcan gene. The glycosaminoglycan
attachment domains GAG a & b are encoded by exon 7 (blue) and 8 (green) respectively. Deletion of exon 7 (blue) results in the loss of both the V2
and V0 variants. Exons 2–6 comprise the G1 domain that binds hyaluronan and 9–15 the G3 domain that also can interact with other ECM molecules.
doi:10.1371/journal.pone.0089133.g001
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4% paraformaldehyde solution. Whole heart samples were then
mounted in precise orientation, processed and cleared for multi-
channel confocal optical sectioning (Leica TCS SP2 SOBS
confocal microscope).
3D Collagen Gel Endothelial-mesenchymal (EMT) Assay
Embryos (E10.5 pc) were dissected from the mouse decidua and
extra embryonic tissues and pooled into Earle’s balanced salt
solution (Gibco). Hearts were dissected from the embryos and the
AV regions were removed, and cut to expose the lumen. The AV
explants were placed immediately onto the surface of drained
collagen gels with 1 explant per well, and incubated at 37uC for 3–
4 hr to allow attachment of the explants onto the collagen gel
surface as previously described [29,30]. A total of 0.5 ml of
DMEM (5% fetal bovine serum, antibiotics) was added to each
well and incubated for a total of 48 hr at 37uC. The number of
Figure 2. Morphological comparison of Vcan(tm1Zim) with wild-type adult hearts. The postnatal Vcan(tm1Zim) hearts showed a dilated right
anterior ventricular wall that was most pronounced in the subpulmonary infundibulum adjacent to the right atrium (asterisks). The dilated right
ventricle gave the apex of the Vcan(tm1Zim) hearts a more rounded external appearance than in wild-type hearts (arrow).
doi:10.1371/journal.pone.0089133.g002
Figure 3. Interventricular septal defects found in the Vcan(tm1Zim) postnatal hearts. An example of IVS defect in the Vcan(tm1Zim) postnatal
day 1 mouse heart (panel B; arrow) associated with a smaller mesenchymalized cushion then those in the wild-type (panel A) at the apex of the
interventricular septum (IVS). RV-right ventricle; LV-left ventricle; IVS-interventricular septum. Magnification bar in panel A= 200 mm and is the same
for panel B.
doi:10.1371/journal.pone.0089133.g003
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mesenchymal cells was assessed by observing the living cultures
with a Zeiss Axiovert 100 inverted microscope with Hoffman
phase contrast optics and ‘‘optically sectioning’’ the collagen gel by
changing focal planes to reveal the presence of any cells beneath
the surface of the endothelial monolayer for counting. Total
mesenchymal cell counts were made from each explant and then
later grouped according to genotype as determined in separate
PCR assays performed after the explant EMT experiments were
scored. Statistical analysis was performed to determine if
significant differences exist between the mean values obtained
from wild-type and mutant using the unpaired (student’s) t-test
within the Prism GraphPad analysis software.
Histology and Immunofluorescence
Hearts dissected from postnatal mice or embryos were fixed in
4% paraformaldehyde, embedded in paraffin, and sectioned as
previously described [19]. For immunohistochemistry, deparaffi-
nized sections were rehydrated through a graded series of ethanol
solutions to phosphate buffered saline (PBS). Hematoxylin and
eosin staining followed standard procedures in the lab. Sections
used for immunostaining were pretreated to unmask any cryptic
antigens using a high-temperature citric acid solution according to
directions (H-3300, Vector Laboratories, Burlingame, CA).
Sections were blocked 1 hr at room temperature with blocking
buffer (PBS, Sigma containing 3% normal goat serum (NGS,
Cappel, Malvern, PA), and 1% bovine serum albumin (catalog no.
B4287, Sigma) then incubated overnight at 4uC with primary
antibody diluted in blocking buffer (anti- GAG-a and -b;
Chemicon, Temecula, CA were diluted to 5 mg/ml; periostin
antibody was diluted to 5 mg/ml. After primary antibody
incubations, specimens were washed 5 times in PBS and incubated
at room temperature with fluorochrome-conjugated secondary
antibody (Jackson Immunoresearch, West Grove, PA) diluted in
blocking buffer. All samples were washed extensively in PBS,
nuclei were labeled with 1 mg/ml propidium iodide (Molecular
Probes C-7590) in PBS for 5 min prior to the final washes in PBS
and slides were cover-slipped using DABCO mounting media
(Sigma). Controls included the use of the secondary antibody only
and use of pre-immune serum. Immunostained sections were
analyzed using a Leica TCS SP2 AOBS Confocal Microscope
Figure 4. Whole-heart confocal optical imaging of defects in Vcan(tm1Zim) E13.5 dpc mouse hearts. In the wild-type (Panel A),
consecutively deeper optical section images showed the pulmonary outlet is ventral to the aortic outlet at the base of the heart. In the Vcan(tm1Zim)
(Panel B), the aorta and pulmonary outlets were within the same plane of optical section due to altered/defective outflow tract rotation and
integration (250 um). Hearts were treated to increase optical transparency and then perfused with FITC conjugated poly-L-lysine to visualize the
endothelial lining of the vessels (yellow/green). Each optical section with each panel is a frontal image taken at sequentially deeper focal planes.
Panels for the wild-type heart (panel A) span a total depth of 200 mm. The Vcan(tm1Zim) heart (panel B) required imaging through a much shorter
distance (125 mm) to image the same structures. RV-right ventricle; A-aorta; P-pulmonary; M-mitral; T-tricuspid.
doi:10.1371/journal.pone.0089133.g004
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System (Leica Microsystems,Inc., Exton, PA). For 3-dimensinal
reconstruction and morphometric analysis micrographs of 7 mm
thick serial sections through E13.5 pc hearts were stacked and
aligned within the AMIRA (v5.4) 3D reconstruction software as
previously described [31,32]. Total volume measurements were
made of the selected structures using the Materials/Statistics tool
for each of the reconstructed hearts (n = 3 for each genotype) and
statistical analysis performed to compare significant differences
between the mean values by unpaired (student’s) t-test using the
Prism GraphPad analysis software.
iTRAQ Analysis
Pregnant females at E13.5 post coitus (pc) were anesthetized
and euthanized following approved protocols of the Division of
Laboratory Animal Resources at MUSC and AAALAC guide-
lines. Hearts of homozygous Vcan(tm1Zim) mutant and wild-type
E13.5 p.c. embryos obtained from multiple litters were removed
by micro-dissection, bisected and rinsed with PBS, frozen in liquid
nitrogen and then finely crushed in a liquid nitrogen cooled
stainless steel mortar and pestle (Model 59012N; BioSpec
Products, Barlesville, OK). Protein profiling was performed on
the pooled hearts of 5 animals from each group in order to obtain
sufficient protein for analysis. The samples were homogenized
(1:10, w/v) in ice cold 20 mM HEPES, pH 8/4uC, containing
1 M urea in a 1 mL ground glass tissue grinder then subjected to
7706g for 10 min at 4uC to remove nuclei and undisassociated
tissue. The resulting supernatants were subjected to centrifugation
at 150,0006g for 90 min at 4uC (Beckman Optima TLX
ultracentrifuge with TKS-55 rotor) to obtain a combined urea
soluble and insoluble fraction. The protein concentration in the
urea soluble fraction was determined by the BCS method (Pierce,
Rockville, IL) using bovine serum albumin as standard. The
samples were reduced and alkylated prior to digestion with LysC
and trypsin at a ratio of 1:10 [33].
Heart preparations from the Wt (wild type), and Vcan(tm1Zim)
mutant E13.5 pc hearts (n = 5 per group) were labeled with the
‘‘isobaric tag reagents for absolute and relative quantitation’’
(iTRAQTM) (Applied Biosystems- Framingham, MA). Duplicate
samples (90 mg of protein each) from wild-type and Vcan(tm1Zim)
mutant hearts were each labeled with one of the 4 unique isobaric
tags (114-wt sample 1; 116-wt sample 2; 115- Vcan(tm1Zim) sample
1; 117- Vcan(tm1Zim) sample 2) and all run in parallel through the
iTRAQ analysis. This strategy created an internal control for the
analysis since the ratio for any one detected protein when
compared to the value for the same protein in the duplicate sample
should equal 1 (114-wt/116-wt and 115-Vcan(tm1Zim)/117-Vcan(tm1-
Zim)). The combined samples were subjected to cationic exchange/
reversed-phase HPLC fractionation and mass spectrometry
analysis for protein identification and quantification. Protein
quantification for all of the iTRAQ peptides found was calculated
using a GPS software and the statistical model for iTRAQ
proteomic analysis [34,35]. The magnitude and significance of
change in protein expression between the two experimental groups
was analyzed using a software package named iQuantitator that is
designed specifically for iTRAQ [35]. The software has been used
in other studies of similar design to ours to identify relevant
proteins for further study from multiple pooled samples grouped
within a single iTRAQ analysis [36–38]. The software infers the
genotype-dependent changes in expression using Bayesian statis-
tical methods. Inference is based on a well-known statistical model
and uses Markov-Chain Monte Carlo methods (Gibbs Sampling).
We generated the means, medians, and 95% credible intervals
(upper and lower) for each genotype-dependent change in protein
expression by using peptide-level data for each component
Figure 5. Three-dimensional reconstructions and quantitative measurements of wild-type and Vcan exon 7 AV associated cushions
in E13.5 pc hearts. The differences found in the mesenchymalized AV cushions, visually apparent in the 3-dimensional comparisons (Panel A,
ventral view; B, dorsal view), were also quantified using the AMIRA imaging software to measure the cushion volumes. A significant reduction in
volume was measured in the central AV cushion comprising the aortic leaflets (AL in panels A, B; reduced 35%; *p,0.034 n= 3 for each genotype,
panel C) and septal (SL in panels A,B; reduced 30% p,0.046 n= 3 for each genotype in panel D). A significant (*p value 0.05 panel G) decrease in
volume (0.58x) of the dorsal mesenchymal protrusion (DM) was measured. The other cushions showed no significant difference and the overall size of
the E13.5 Vcan(tm1Zim) and wild-type hearts (measured by tissue weight) was not significantly different (74 mg and 75.6 mg respectively; n = 3 for
each genotype). AL-aortic leaflet (red); PL-parietal leaflet (blue); SL-septal leaflet (pink); ML-mural leaflet (green); DM-dorsal mesenchyme (white).
doi:10.1371/journal.pone.0089133.g005
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peptide, and integrating the data across the control and
experimental group of pooled samples. For proteins whose
iTRAQ ratios were down regulated in the pooled null hearts,
the extent of down-regulation was considered further if the null
value of 1 was above the upper limit of the credible interval.
Conversely, for proteins whose iTRAQ ratios were up-regulated in
null hearts, the extent of up-regulation was considered further if
the lower limit of the credible interval had a value greater than 1.
The width of these credible intervals depends on the data available
for a given protein. Since the number of peptides observed and the
number of spectra used to quantify the change in expression for a
given protein are taken into consideration, it is possible to detect
small but significant changes in up- or down-regulation when
many peptides are available.
Western Blot Analysis
Hearts of homozygous Vcan(tm1Zim) mutant and wild-type E13.5
p.c. embryos were obtained by microdissection and proteins
extracted as described for iTRAQ analysis. The protein concen-
tration in the urea soluble fraction was determined by the BCS
method (Pierce, Rockville, IL) using bovine serum albumin as
standard. Protein samples (20 mg) from individual hearts were
electrophoresed on 4–15% SDS–PAGE gels essentially as we have
previously described [39,40]. Briefly, separated proteins were
transblotted onto nitrocellulose membranes, blocked for non-
specific protein binding using 5% dry milk 50 mM Tris, pH7.2/
150 mM NaCl/0.5% Tween 20 (TBST) and then probed for
selected proteins with specific primary antibody followed by
secondary peroxidase labeled antibody for detection. The specific
primary antibodies used were rabbit anti- Hsp 47 (1:5,000; MBL
international), rabbit anti-Stathmin (1:2,000 dilution; Sigma),
rabbit anti- Desmin (1:5,000 dilution; Sigma) goat anti-rabbit-
HRP (1:10,000 dilution; Jackson immunoResearch) secondary
antibody (Sigma). Immunopositive bands were detected using
ECL (Pierce). Multiple exposures of x-ray film were made with the
ECL treated membrane to assure that the developed band
densities were within the linear range of the film. Imaging was
performed using an imaging camera system (Chemimager 4400;
AlphaInotech) with no auto-gain [41]. Measurements to determine
the relative densities were normalized to Desmin using NIH image
J [42]. The relative density measurements obtained from 5
Figure 6. Three-dimensional reconstruction and quantitative comparisons of wild-type and Vcan exon 7 cardiac OT associated
cushions in E13.5 pc hearts. Significant differences were found in the volume of the pulmonary lumen and size of the pulmonary cushions in the
Vcan(tm1Zim) compared to wild-type littermates. The differences, visually apparent in the 3-dimensional comparisons (panel A; wild-type and
Vcan(tm1Zim)), were quantified using the AMIRA imaging software to measure the volumes of the cushion primordia of the pulmonary and aortic
valves and of the pulmonary (brown) and aortic (purple) lumens. A significant increase (51%; *P value 0.047 panel D) was found in the size of the
pulmonary cushions in the Vcan(tm1Zim) hearts compared to wild-type littermates (panels D). The pulmonary lumens of the Vcan(tm1Zim) cardiac outlets
were found to be significantly (panel E; *P value 0.028 ) smaller (57%) then that of wild-type littermate controls. The aortic lumen volumes measured
smaller but did not show a significant change (panel C). Brown-pulmonary lumen (PL); purple-aortic lumen (Ao); green-pulmonary cushions; yellow-
aortic cushions.
doi:10.1371/journal.pone.0089133.g006
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individual homozygous hearts were averaged and analyzed with
Prizm 5 (GraphPad software, Inc).
Results
Septal Defects in the Vcan(tm1Zim) Mice
Gross and histological examination of the Vcan(tm1Zim) hearts
showed an altered external morphology and the presence of heart
defects. External examination of the postnatal Vcan(tm1Zim) hearts
showed a dilated right ventricular wall that was most pronounced
in the subpulmonary infundibulum adjacent to the right atrium
(Fig. 2; asterisks). The dilated right ventricle also gave the apex of
the Vcan(tm1Zim) hearts a more rounded external appearance than
in wild-type hearts (Fig. 2; arrow).
Histological examination showed that many of the homozygous
Vcan(tm1Zim) hearts achieved normal internal septation. However,
AV cushions in all the Vcan(tm1Zim) hearts were smaller than those
found in the wild-type hearts (see below) and ventricular septal
defects were observed (Fig. 3; 37%; 14 of 38 postnatal day 1
hearts). Also, an abnormal relationship was observed between the
aortic and pulmonary roots in the mutant hearts. Combined, these
structural defects suggested developmental alterations in the
mutants at or around embryonic stage 13.5 pc when there is a
closure of membranous portion of the interventricular septum and
the cardiac outlet is integrated into the central cushions [43]. To
explore this hypothesis, we used confocal optical sectioning of
E13.5 dpc hearts that were rendered semi-transparent to compare
the relative orientation of the aortic and pulmonary roots at
sequentially deeper Z-planes. Using this technique in the wild-type
heart, we found the pulmonary outlet was imaged in a more
ventral plane of optical section (Fig. 4A, Z-plane 0 to 240 mm)
relative to the aortic outlet that appeared in a deeper Z-plane level
(Fig. 4A, Z-plane 2120 to 2200 mm) as expected for a normal
mouse heart. However, imaging of the mutant heart showed that
both the pulmonary and aortic roots are abnormally found within
the same Z-plane of optical section (Fig. 4B, Z-plane 225 through
250 mm). The homozygous phenotypes were consistent with a
common underlying problem occurring in the final developmental
stages of the outflow tract’s integration into the base of the heart
that is occurring at E13.5 pc in the mouse.
Altered Atrioventricular and Outflow Tract Structures in
the Vcan(tm1Zim) Hearts
Histological three-dimensional (3D) reconstructions of the
Vcan(tm1Zim) hearts at E13.5 pc showed significant differences in
the size of the central AV endocardial cushions of the heart
(Fig. 5A,B). Both the mesenchymalized aortic and septal leaflet
cushions of the AV canal were significantly reduced in total
Figure 7. Histological comparison of cushions in the Vcan(tm1Zim). Hematoxylin/eosin stained sections of postnatal day 1 (B, D) and
Vcan(tm1Zim) (A, C) hearts were compared. Boxed region in A and B of the cushion is shown higher magnification in C and D. Note the smaller cushions
in the Vcan(tm1Zim) heart. Panel A and B are the same magnification as are C and D; magnification bars = 200 mm.
doi:10.1371/journal.pone.0089133.g007
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volume in the Vcan(tm1Zim) hearts as determined by AMIRA 3D
reconstruction measurements (Fig. 5C,D). Similar measurements
of the parietal leaflet of the right AV and the mural leaflet of the
left AV showed no significant difference in total volume between
Vcan(tm1Zim) and wild type littermates (Fig. 5E, F). The dorsal
mesenchymal protrusion was smaller in volume and did not
integrate fully into the central AV cushion complex (Fig. 5B,G). In
the cardiac outlet, measurements of the forming pulmonary leaflet
cushions showed a significant (51%) increase in total volume in the
Vcan(tm1Zim) (Fig. 6A, D). Whereas, the total volume occupied by
the cushions of the aortic leaflets were of similar size (Fig. 6A,B). In
addition, the lumen of the pulmonary artery is significantly smaller
in the Vcan(tm1Zim) compared to the wild-type animals (Fig. 6A, E)
The lumen of the ascending aortic artery showed no significant
difference between Vcan(tm1Zim) and wild-type animals (Fig. 6A,C).
In newborn (postnatal day1) hearts, the Vcan(tm1Zim) leaflets also
appeared smaller than those found in the wild-type littermate
controls (Fig. 7). The density of mesenchymal cell nuclei in the AV
cushions was reduced in the Vcan(tm1Zim) hearts (62% of wild-type;
average of 8 nuclei/160 um2 vs. 13 nuclei/160 um2 respectively;
SD=1.8; n= 4; p = 0.01). Cushion explants from the AV regions
of Vcan(tm1Zim) hearts cultured on 3D hydrated collagen gels (EMT
assay) [29,30] produced fewer mesenchymal cells below the
surface of the gel compared to wild-type littermate controls (Fig. 8).
Localization of Extracellular Matrix (ECM) Molecules in
the Adult Valvular Cushions and Great Arteries
Versican is prominently expressed in the mature cardiac valves,
and the great arteries [44–46]. To morphologically assess any
detectable changes in versican and other specific ECM markers
that result from the loss of the V2/V0 splice forms we evaluated
the structures in adult hearts (5 K weeks postnatal) by confocal
indirect immunofluorescence. Antibodies recognizing either exon
7 (GAG-a) or exon 8 (GAG-b) domains of versican were used to
differentiate between the expression of the full length and
alternative splice forms V1 and V2. Both antibodies recognize
the V0 splice form, however, it is absent in the Vcan(tm1Zim) mouse.
Results confirmed that, as expected, the GAG-a/exon 7 antibody
did not react with the Vcan(tm1Zim) hearts since the polypeptide
region containing the epitope recognized by this antibody is
missing in the Vcan(tm1Zim) mouse (Fig. 9B). Localization in wild-
type hearts of the GAG-a/exon 7 epitope was most intense along
the ventricular side of the aortic leaflets plus the luminal and
external regions of the aortic wall. Strong localization was also
found in the interstitium of the heart myocardium within the
interventricular septum (IVS) near the hinge region of the valvular
leafets, the aortic mitral continuity and atrial myocardium
(Fig. 9A).
Immunolocalization of the GAG-b/exon 8 epitope, found in
both V0 and V1 versican, was localized throughout all valvular
leaflets in both the wild-type and the Vcan(tm1Zim) hearts
(Fig. 9C&D). However, little or no staining was seen within the
interstitium of the myocardium (e.g., interventricular septum) for
this eiptope in either wild-type or Vcan(tm1Zim) hearts.
We hypothesized that the exon 7 containing variants of Vcan
may participate in the organization of other ECM molecules. To
further assess alterations in the Vcan(tm1Zim) extracellular matrix the
protein periostin was evaluated in embryonic and adult hearts
because it is expressed in a close pattern with versican in
developing cushions and adult structures [19,45]. We chose E13.5
dpc developmental stage, since this is an embryonic stage that
exon 7 epitope is clearly detectable at the protein level. Figure 9,
shows the confocal immunofluorescence image comparisons of
periostin, in embryonic (E13.5) and adult Vcan(tm1Zim) and wild-
type hearts. Staining for periostin appeared more abundant and
fibrillar in the Vcan(tm1Zim) (Fig. 10 B,D) than observed in wild-type
(Fig. 10 A,C) endocardial cushions of E13.5 pc embryonic hearts.
In the wild-type adult heart periostin staining localized to the
aortic wall, valve leaflets, and the myocardial interstitial tissue of
aortic mitral continuity (Fig. 10E). Staining was also apparent in
interstitial tissues of the myocardium at the base of the aortic valve
leaflet in the interventricular septum of the wild-type hearts
(Fig. 10E). In the Vcan(tm1Zim) hearts, periostin was detected in a
similar pattern, but with more intensity in the walls of the aorta
(Fig. 10F). Also, the interstitial localizations of periostin in the
interventricular septum showed a more restricted pattern of
localization between the myocardial cells in the Vcan(tm1Zim) hearts
(compare IVS of wild-type and mutant in Fig. 10E,F). Overall, the
loss of the Vcan variant appears to alter periostin’s deposition
pattern in the matrix.
Vcan(tm1Zim) Hearts have Deficiencies in Cushion Tissue
Muscularization
Immunohistological analysis of the Vcan(tm1Zim) hearts (E13.5 pc)
showed a lack of cells positive for a-sarcomeric actin within the
mesenchyme of the right parietal leaflet and reduced amounts in
the central mesenchymalized cushions (Fig. 11). Regions of the
endocardial cushions Vcan(tm1Zim) become muscularized during the
late stages of embryonic development through a process of
differentiation or myocardial cell invasion [47,48]. In the
Vcan(tm1Zim) E13.5 hearts, cells positive for of a-sarcomeric actin
staining are completely absent within the cushion mesenchyme of
the right parietal leaflet (Fig. 11 A,B,C,D and Fig. 12 ). Also the
Vcan(tm1Zim) hearts have a diminished level of a-sarcomeric actin
staining in the central regions of mesenchyme formed by the spina
vestibule and dorsal mesenchymal protrusion (Fig. 12 B; single
arrow).
Figure 8. Epithelial-mesenchymal 3D gel assay. Atrioventricular
cushion explants from E10.5 pc hearts cultured on 3D hydrated
collagen gels in the EMT assay produced significantly (p,0.05) less
numbers of mesenchymal cells found below the surface of the gel from
explants of Vcan(tm1Zim) mice (average 37/explant; n = 3) vs. wild-type
littermate controls (average 55/explant; n = 3).
doi:10.1371/journal.pone.0089133.g008
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Proteomic iTRAQ Analysis of the Vcan(tm1Zim) Hearts
To identify some of the resulting differences in cellular protein
abundance that results from the loss of the extracellular Vcan splice
forms, a high-throughput quantitative proteomic analysis (iTRAQ;
Applied Biosystems) was used. Protein extractions were made of
separately pooled E13.5 pc Vcan(tm1Zim) (n = 5) hearts and wild-
type (n = 5) hearts. Replicate aliquots of the WT and Vcan(tm1Zim)
heart homogenates were labeled with unique isobaric tags for
separate analysis. The separate protein fractions were then
analyzed by iTRAQ to profile the identities and relative changes
in abundance. The replicate aliquots from the same groups
allowed for controlled comparisons within each group. Therefore,
as an internal control the ratio of protein abundance for each
identified protein within the same (Vcan(tm1Zim) or wt) replicate
aliquot should yield a value of 1.0. Only those that deviated from a
ratio of 1.0 were considered to represent a unique protein
fingerprint for Vcan(tm1Zim) hearts compared to wild-type. Identi-
ties, relative abundance and statistical analysis of multiple peptides
mapping to individual proteins were performed on the data using
methods and software previously described [35].
A total of 5095 redundant iTRAQ pairs were identified for the
Vcan(tm1Zim) and WT fractions. A total of 2882 unique peptides
were identified, corresponding to 940 proteins. Well over 50% of
the proteins identified were represented by two or more unique
peptides. Only those proteins with at least two unique peptides are
reported. Forty-seven proteins showed significant increases in the
mean expression ratio of abundance by more than 1.20-fold in the
Vcan(tm1Zim) mouse heart and 74 were decreased by more than
0.85X (File S1). The relative change in protein abundance
measured by iTRAQ was verified for selected proteins of interest
by western blots of E13.5 pc staged heart extracts. As predicted,
the relative abundance of Vcan in the Vcan(tm1Zim) hearts was
reduced (0.45x) in abundance compared to the wild-type. Other
proteins of interest were surveyed in western blots to verify the
relative change in abundance detected by iTRAQ. For example,
Annexin A6 (4 unique peptides) and Stathmin 1 (9 uniques
peptides) together showed a relative decrease (0.85 and 0.73
respectively) in the Vcan(tm1Zim) heart. Also, all 3 peptides mapped
to Serpinh1 (Hsp 47) showed an increased abundance (1.55) in the
Vcan(tm1Zim). The relative decreases or increase was confirmed by
western blots of protein in more than one animal (Stathmin, Hsp
Figure 9. Comparisons of versican domains in the Vcan(tm1Zim) and wild-type adult hearts. Immunohistological localization of the GAGa
antibody (epitope found in exon 7) showed no immunofluorescence in the Vcan(tm1Zim) heart (B). GAGa antibody in wild-type hearts (A) localized to
the aortic walls and valves (arrowheads), interstitial tissue of the interventricular septum (IVS) and of the aortic mitral continuity (arrow). The GAGb
antibody (epitope found in exon 8) was localized in the Vcan(tm1Zim) (D) to the aorta walls, valvular leaflets (arrowheads), IVS and aortic mitral
continuity, but GAGb positive cells were not found interspersed between the sarcomeric myosin positive cells (arrow) of the aortic mitral continuity
as seen in the wild-type heart (E). Within the wild-type interstitial tissue of the interventricular septum myocardium and aortic mitral continuity GAGb
localization was relatively absent compared to the GAGa localization in these regions (compare IVS- arrows in A and C; identical confocal settings).
The magnification bar in panel A = 200 mm applies to all panels. Ao-aorta; IVS-interventricular septum.
doi:10.1371/journal.pone.0089133.g009
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47 and Desmin, n= 3; Annexin A6, n = 2; Fig. 13). The relative
changes in density were significant and normalized in the
immunoblot to Desmin that measured with a mean expression
ratio average of 0.92 for all 22 peptides identified. We sorted the
Figure 10. Comparison of periostin in the cushions and valves of Vcan(tm1Zim) embryonic and adult hearts. Comparisons of periostin
expression in wild-type E13.5 pc hearts (panels A, C) and Vcan(tm1Zim) E13.5 pc hearts (panels B,D) by confocal immunofluorescent localization.
Periostin (green) expression in the Vcan(tm1Zim) hearts appeared more compact and less widely distributed throughout the cushions than in the wild-
type. Boxes in panels A,B denote magnified areas shown in C,D. Periostin staining showed a sharper boundary between the apex of the
interventricular septum (blue; a-sarcomeric myosin) and the adjacent cushion mesenchyme in the Vcan(tm1Zim) (D; arrow) as compared to that
observed in wild-types (C; arrows). In adult hearts, periostin expression in the Vcan(tm1Zim) (F) appeared more intense in the aorta (Ao) walls and valve
leaflets, however very little or no localization of periostin was observed in the interstitial tissue of the muscular interventricular septum (IVS) as
compared to wild-type (E). In the Vcan(tm1Zim) heart, periostin appeared to localize only in zones adjacent to the myocardium (F;IVS), but did not show
an interspersed pattern of expression between individual myocytes as seen in the wild-type IVS and aortic mitral continuity(E;IVS). Panels A & B same
magnification bar = 150 mm; panels C & D same magnification bar = 50 mm; panels E & F same magnification bar = 200 mm.
doi:10.1371/journal.pone.0089133.g010
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Figure 11. Restricted or delayed process of myocardialization observed in the Vcan(tm1Zim) hearts. E13.5 pc wild-type hearts (A, B)
compared to Vcan(tm1Zim) (C, D). The image in each panel is one taken from sections through the right parietal cushions at their thickest margin.
Panels A and C utilize both periostin staining (green) and a-sarcomeric actin (red) to mark the cushion and muscle boundaries (propidium iodide
marks the cell nuclei in blue). Panels B and D are the same image as A and C with periostin and propidium iodide staining removed to show the
extent of muscle cells (a-sarcomeric actin positive) present within the cushion more clearly (A & B; arrows mark the muscle boundary; dotted lines
mark the boundaries of the cushion). The WT hearts show that muscle cells are present in the cushion. The Vcan(tm1Zim) hearts show little or no
presence of muscle into the adjacent matrix of the phenotypically smaller cushions of the Vcan(tm1Zim) hearts (B, C). IVS-interventricular septum.
Magnification bar in panel A= 100 mm and applies to all panels.
doi:10.1371/journal.pone.0089133.g011
Figure 12. Four-chambered view of the wild-type (A) and Vcan(tm1Zim) E13.5 hearts (B) show a diminished level of a-sarcomeric actin
staining (arrow in A & B) in the mesenchyme of the central AV cushion consisting of the dorsal mesenchymal protrusion and spina
vestibule as compared with the wild-type hearts (B). A complete lack of a-sarcomeric actin staining was observed in the cushion of the right
AV parietal leaflet cushion in the Vcan(tm1Zim) (B; within the area bounded by the dotted line), but a-sarcomeric actin staining was clearly present in
the same leaflet cushion of the wild-type (A; within the dotted line). Double arrowheads in A and B denote the septal AV leaflet cushion. RA-right
atrium; LA-left atrium; RV-right ventricle, LV-left ventricle. Magnification bar 100 mm.
doi:10.1371/journal.pone.0089133.g012
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proteins found to change in abundance in the Vcan(tm1Zim) hearts
into standard gene ontology (GO) categories (File S2). The gene
ontology categories for altered protein levels showed that the loss
of Vcan exon7 alters cellular processes at multiple levels including
those that would likely underlie the observed heart and vasculature
phenotype. These include altered abundance of proteins needed in
extracellular matrix assembly, signal transduction, muscle differ-
entiation/function, apoptosis and proliferation.
Discussion
Since the initial identification and characterization of versican
[3], the functional importance of this chondroitin sulfate
proteoglycan in multiple adult biological systems has been
increasingly demonstrated [49–51]. Similarly, the expression
pattern of versican in embryogenesis and analysis of the insertional
mutant mouse hdf have shown that versican is indispensable during
the early formation of the heart [5,52] and at later stages is needed
for closure of the interventricular foramen [22,32]. The expression
of alternative splice forms, within specific cardiac tissue domains in
the later stages of heart development has suggested that versican
splice forms may play important specific roles in the later
embryonic and fetal stages of heart formation. In this study, we
show a requirement for exon 7 containing versican splice forms
V0/V2 during normal heart development at later stages that
impact the mature heart structure. Detailed analyses of the
Vcan(tm1Zim) mice revealed septal defects, changes in the size of
some mesenchymalized cushions, dilated right ventricle with
dilation of the sub-pulmonary infundibulum and altered integra-
tion of the aortic and pulmonary trunks into the AV cushion
complex. These combined altered phenotypes result in a failure of
the outflow tract to integrate and align correctly with the ventricles
during development.
We observed the presence of VSDs in the Vcan(tm1Zim) hearts.
Closure of the interventricular foramen occurs at approximately
E13–14 p.c. in the wild-type mice on the C57B6 background. In
the E13.5 p.c. hearts, analyzed by AMIRA 3d reconstruction,
forming cushions of the dorsal mesenchymal protrusion, septal and
aortic leaflets were significantly smaller and did not merge as in
wild-type. This reduction in cushion tissue could contribute to the
higher incidence of VSD at E13.5, however many of these defects
eventually close as was observed shortly after weaning of the
newborn mice (5.5 weeks PN; 37% VSD). The presence of
ventricular septal defects have been described in other mouse
models of Vcan partial depletion that include the Crtl-1 null, hdf
heterozygous and the Vcan subdomain A null mouse (VcanD3/D3)
[22]. Comparison of Vcan(tm1Zim) exon mouse heart defects with the
Crtl1-null and the hdf heterozygote models show this overlap in
structural defects (e.g. VSD) [32], but also an additional spectrum
of cardiac outlet defects in the Vcan(tm1Zim) reported here. We also
know that hdf heterozygous [32] and Vcan(tm1Zim) heart have
reduced levels (approximately 50%) of versican. Similarly, the
expression of the truncated Vcan gene in VcanD3/D3 is approxi-
mately 55% of the wild type, The hdf heterozygote is able to
express all splice forms of Vcan from its unaffected allele, the Vcan
D3/D3 expresses an altered form containing the G3 domain and the
Vcan(tm1Zim) can only expresses 2 of the 4 alternative splice form
variants. Taken together the observations suggest that the VSDs
observed in all 3 models are the result of an overall reduction in
versican expression and not specifically due to the splice variants
expressed.
The process by which the outflow tract becomes aligned with
the ventricles involves the integration of the proximal outflow tract
cushion into the central mesenchymalized cushion of the E13.5
Figure 13. Western blot comparison of four proteins with
altered abundance by itraq in Vcan(tm1Zim) mutant and wild-type
hearts. Proteins that showed different levels of altered abundance in
the Vcan(tm1Zim) hearts are shown in the blot. Annexin A6 and Stathmin
are proteins expressed in the heart that showed a relative decrease
(0.85x and 0.73x respectively) in abundance in the Vcan(tm1Zim) mutant
by iTRAQ and serphin1 (Hsp 47) that by iTRAQ showed increased
abundance (1.55x). Additionally, Desmin that did not change with any
significance between mutant (Mut) and wild-type (Wt) by iTRAQ,
showed no significant change by western blot. Results of average
relative density measurements of separately analyzed hearts are shown
in the graph for each protein (for Stmn, Hsp47, Desmin n= 3; p,0.01;
for Annexin A6 n=2; p,0.0045).
doi:10.1371/journal.pone.0089133.g013
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p.c. heart. This positions the aortic and pulmonary arterial trunks
in proper alignment between the left and right ventricular canals
(Fig. 14). The mechanism through which this integration occurs is
not well understood, however, part of the process involves the loss
of inner curvature muscle and the appearance of cardiac muscle
within the adjacent cushion mesenchyme. This process has been
termed myocardialization [48,53,54]. The inner curvature mus-
culature is removed by myocardialization during the final stages of
looping that brings the proximal outlet segment septum (conus
septum) into proper alignment with the ventricles of the 4-
chambered heart. Changes in the size of mesenchymalized
cushions and related changes in the myocardialization process
has been observed in other models that have incomplete cardiac
outlet integration e.g., the Vang12 null, [54,55]Tgfß- 2 null [48],
Trisomy 16 mouse [56,57] and connexin 43 null [58].
Both the right mural and the central AV mesenchymalized
cushions in Vcan(tm1Zim) heart show evidence of less myocardializa-
tion. The Vcan(tm1Zim) hearts at E13.5 pc showed reduced numbers
of cells positive for a-sarcomeric actin within both these cushions
(Fig. 11 & 12). This suggests a reduced ability of these cushions to
undergo the normal process of myocardialization in the absence of
Vcan splice forms V0/V2. This could be due to 1) a non-permissive
matrix environment in the cushion that does not promote or
prevents myocardial differentiation and/or invasion of needed
precursor cells; 2) inability of the cushion matrix to sustain the
myocardial phenotype within the cushion. The loss of Vcan exon 7
containing alternative splice forms V0/V2 may directly result in a
‘‘non-permissive’’ matrix, or indirectly alter other ECM molecules
to interfere with invasion and/or myocardial phenotypic stability.
We have shown that there are overall fewer cushion mesenchymal
cells in the Vcan(tm1Zim) heart. It should be noted that the time
points chosen for this study might not be entirely sufficient to fully
understand the mechanisms of the valvular defects. Others have
shown that a sufficient threshold level of cushion mesenchyme is
essential for myocardialization to occur using in vitro assays that
model the process [59]. The precise role of the cushion
mesenchyme remains unclear, however, indications are that these
cells produce an inductive signal (e.g., growth factor) that triggers
the myocardial invasion [60]. However, a lack of myocardializa-
tion has been reported in both hypo-mesenchymal [56] and hyper-
mesenchymalized heart cushions [48]. This suggests that the
absolute number of total mesenchymal cells may not be the most
important factor for myocardialization to proceed. Reduced
myocardialization may reflect reduced levels of an inductive
factor or a reduced number of one or more cell subpopulations
that contribute to the heart cushions [61–67].
Because versican is an extracellular matrix molecule, the cellular
responses reflected by the differentially expressed proteins are
likely due to the cells interaction with an altered ECM. Periostin is
an important molecule of the heart cushion extracellular matrix
[68] and showed an altered distribution in Vcan(tm1Zim) mutant
cushions. Vcan induced changes in periostin distribution may
effect the developing valves by altering the structural integrity of
the ECM through altered interaction with other molecules such as
tenascin-C, fibronectin, collagen and other proteoglycans
[40,69,70]. Additionally, because it interacts directly with integrin,
attachment-dependent signaling [71,72] may be altered affecting
cell migration and epithelial mesenchymal transition in the
cushion primordia of the septa and valves. We identified by
ITRAQ analysis changes in other proteins involved in extracel-
lular matrix organization and cell response. These include
serpinh1 (Hsp 47) that is required for normal collagen deposition
Figure 14. Normal rotation and integration of the outflow tract (cardiac outlet) into the fused atrioventricular (AV) cushion in the
final stages of looping and septal alignment. Upper panels are cross section dorsal views showing left and right AV canals, aorta and
pulmonary trunks (Ao & P). Lower panels are depictions of the sagittal view. The dotted line indicates approximate section shown in upper panels.
The myocardium (*inner curvature) between the outlet and AV cushion is removed and myocardial cells invade the proximal outlet cushion as in
E12.5. P-pulmonary artery, Ao-aorta, LAV & RAV, left & right atrioventricular canals, M-mitral valve, T-tricuspid valve.
doi:10.1371/journal.pone.0089133.g014
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[73]. Also, calreticulin required for collagen deposition and fibulin
5 needed for elastin assembly showed reduced abundance in the
mutant heart by iTRAQ and are candidates for future investiga-
tion [74,75]. Both of these last two ECM molecules are important
for development and maintenance of the great arteries. In
addition, changes in abundance were measured in ECM signal
transduction proteins. Annexin A6 (reduced 75%) has been shown
to directly bind versican and is a putative cell surface receptor for
chondroitin sulfate proteoglycans [76]. This Ca++ regulatory
protein is highly expressed in various cells of the heart and
modulates EGFR stimulated Ca++ influx [77]. Inhibition of
Annexin A6 expression by siRNA enhances EGF stimulated
phosphorylation in the Ras/MAPK pathway [78,79]. It is also
interesting, but not yet verified independently, that changes were
measured by iTRAQ in the proteins Fkbp1a and Rbpms that both
regulate the ECM associated Smad pathway that may potentially
play a role in the mutant phenotype. Also, the dilated right
ventricular phenotype in the Vcan(tm1Zim) hearts correlated with
protein abundance changes identified in the proteomic results.
Among these, a protein that showed changes in abundance by the
iTRAQ analysis was LIM domain binding 3 isoform b also known
as cypher/ZASP. Cypher/ZASP is a member of the family of
proteins containing a PDZ domain at their amino terminus and
LIM domains at their COOH terminus. Cypher null mice display
a severe form of congenital myopathy and die postnatally from
functional failure in multiple striated muscles [80]. Mutations in
the human homolog of cypher/ZASP have been associated with
dilated cardiomyopathy and left ventricular non-compaction [81–
84]. Reduction in the abundance of vimentin was also noted by
iTRAQ in the Vcan(tm1Zim) and may be related to the observed
lower mesenchyme cell density in the endocardial cushions. The
versican V1 (exon 8 containing) splice form still present in the
Vcan(tm1Zim) down regulates the expression of vimentin in NIH 3T3
cells [85]. Although vimentin expression is not normally abundant
in adult cardiac myocytes, it is upregulated in regenerating [86]
and embryonic myocytes during differentiation [87]. It should be
noted that the ITRAQ proteomic results do not represent the
entire proteome and that these data would need further validation
and functional experiments to make a link with any candidate
protein and the observed defects.
In conclusion, the defects in cardiac phenotype and alterations
in protein abundance reported in this study show that the versican
splice forms V1/V2 containing exon 7 are important for
regulation of cardiac cushion size and the myocardial remodeling
required for the proper integration of the outflow tract into the
base of the heart.
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